Piet ter Wee, VU Medical Center Amsterdam, The Netherlands, Phone: +31(0) 20-4442673, Mail:
J Nutr Health Aging. 2016;20(9):944-951. doi: 10.1007/s12603-016-0709-y.
BACKGROUND/OBJECTIVE: High protein oral nutritional supplements (ONS) are regularly prescribed to undernourished patients; however usage of these in older adults is being discussed, as their renal function might have declined with age. Therefore, the aim of the current study was to evaluate the effects of 8 week long consumption of high protein ONS on the renal function of nursing home residents in need of supplementation. Furthermore, within the same setup, differences in gastro-intestinal tolerance between a standard and a more concentrated version of an ONS were investigated.
Randomized, controlled, single-blind, parallel-group, multi-country trial (NTR2565).
Nursing home.
67 nursing home residents in need of ONS (energy-dense, small volume group n=32; standard volume group n=35).
Protein supplementation was provided by either a standard (200ml, 300kcal, 20g protein) or an energy-dense, small volume (125ml, 300kcal, 18g protein) ONS during the 8 week long study.
Primary outcome was gastro-intestinal tolerance, assessed by daily stool frequency and consistency, and occurrence and intensity of self-reported gastro-intestinal symptoms. Safety was measured via the occurrence of (serious) adverse events, vital signs, as well as liver- and kidney function monitoring.
No clinically relevant and, except for flatulence, no statistically significant differences in gastro-intestinal tolerance were observed between groups. No significant difference between groups was found for estimated glomerular filtration rate (eGFR) and urinary albumin/creatinine ratio at baseline and week 8, nor for the changes from baseline. Adverse events and the changes in monitored renal parameters over the study period did not point to a deterioration of renal function.
High protein ONS seems to be well-tolerated and safe; there is no indication that it affects renal function in nursing home residents, including patients with stage 3 chronic kidney disease, under the conditions tested. Results did not suggest a difference in the effect on renal function between standard and energy-dense small volume ONS format.
背景/目的:高蛋白口服营养补充剂(ONS)经常被开给营养不良的患者;然而,由于老年人的肾功能可能随年龄增长而下降,因此正在讨论在老年人中使用这些补充剂。因此,本研究的目的是评估 8 周高蛋白 ONS 摄入对需要补充的养老院居民肾功能的影响。此外,在相同的设置中,还研究了 ONS 的标准和更浓缩版本之间在胃肠道耐受性方面的差异。
随机、对照、单盲、平行组、多国试验(NTR2565)。
养老院。
67 名需要 ONS(高能量、小体积组 n=32;标准体积组 n=35)的养老院居民。
在 8 周的研究中,通过标准(200ml,300kcal,20g 蛋白质)或高能量、小体积(125ml,300kcal,18g 蛋白质)ONS 提供蛋白质补充。
主要结局是胃肠道耐受性,通过每天的粪便频率和稠度以及自我报告的胃肠道症状的发生和强度来评估。安全性通过(严重)不良事件、生命体征以及肝肾功能监测来衡量。
除了腹胀外,两组之间在胃肠道耐受性方面没有观察到临床相关且无统计学意义的差异。两组在基线和第 8 周时的估计肾小球滤过率(eGFR)和尿白蛋白/肌酐比值以及从基线的变化均无显著差异。研究期间监测的肾功能参数的不良事件和变化并未表明肾功能恶化。
高蛋白 ONS 似乎耐受性良好且安全;在测试条件下,没有迹象表明它会影响养老院居民的肾功能,包括患有 3 期慢性肾脏病的患者。结果并未表明标准和高能量小体积 ONS 形式对肾功能的影响有差异。